Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 5th edition, 486 pages

Free download


  COVID-19

  Free Subscription


26.10.2020

1 Acad Emerg Med
2 AJR Am J Roentgenol
2 Am J Obstet Gynecol
10 Am J Respir Crit Care Med
12 Ann Intern Med
1 Antiviral Res
45 BMJ
1 Clin Chem
22 Clin Infect Dis
10 Emerg Infect Dis
3 Eur J Radiol
6 Infect Control Hosp Epidemiol
14 Int J Infect Dis
5 Intensive Care Med
1 J Infect
25 J Med Virol
1 J Thorac Oncol
4 J Travel Med
1 J Virol
38 JAMA
11 Lancet
1 Lancet Child Adolesc Health
4 Lancet Glob Health
6 Lancet Infect Dis
5 Lancet Psychiatry
5 Lancet Respir Med
2 Life Sci
12 MMWR Morb Mortal Wkly Rep
19 N Engl J Med
14 Nature
1 Radiology
16 Science
1 Travel Med Infect Dis


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acad Emerg Med

  1. WYNTER C
    Inequities of the COVID-19 Pandemic Among Minority Populations: My Family's Struggle to Survive.
    Acad Emerg Med. 2020 Oct 20. doi: 10.1111/acem.14154.
    PubMed         Abstract available


    AJR Am J Roentgenol

  2. CHEN L, Liang W
    Imaging Evaluation of Coronavirus Disease (COVID-19) Pneumonia in Pregnant Women.
    AJR Am J Roentgenol. 2020 Oct 14:W1. doi: 10.2214/AJR.20.24626.
    PubMed        

  3. HANNA TN, Steenburg SD, Rosenkrantz AB, Pyatt RS Jr, et al
    Emerging Challenges and Opportunities in the Evolution of Teleradiology.
    AJR Am J Roentgenol. 2020 Oct 14:1-6. doi: 10.2214/AJR.20.23007.
    PubMed         Abstract available


    Am J Obstet Gynecol

  4. PATBERG ET, Adams T, Rekawek P, Vahanian SA, et al
    COVID-19 Infection and Placental Histopathology in Women Delivering at Term.
    Am J Obstet Gynecol. 2020 Oct 19. pii: S0002-9378(20)31194.
    PubMed         Abstract available

  5. MEYER R, Friedrich L, Maixner N, Bart Y, et al
    A marked decrease in Preterm Deliveries during the COVID-19 Pandemic.
    Am J Obstet Gynecol. 2020 Oct 15. pii: S0002-9378(20)31191.
    PubMed         Abstract available


    Am J Respir Crit Care Med

  6. SANFILIPPO F, La Rosa V, Oliveri F, Astuto M, et al
    COVID-19, Hypercoagulability and Cautiousness with Convalescent Plasma.
    Am J Respir Crit Care Med. 2020 Oct 21. doi: 10.1164/rccm.202008-3139.
    PubMed        

  7. JHA AK
    Pulmonary Vascular Changes in Acute Respiratory Distress Syndrome Due to COVID-19.
    Am J Respir Crit Care Med. 2020 Oct 21. doi: 10.1164/rccm.202009-3508.
    PubMed        

  8. ARACHCHILLAGE DJ, Desai SR, Devaraj A, Ridge CA, et al
    Reply to: Sanfilippo et al Caviedes et al.
    Am J Respir Crit Care Med. 2020 Oct 21. doi: 10.1164/rccm.202008-3340.
    PubMed        

  9. CHEN L, Tang R, Chen H, Huang Y, et al
    Pulmonary Vasculature: A Target for COVID-19.
    Am J Respir Crit Care Med. 2020 Oct 21. doi: 10.1164/rccm.202009-3564.
    PubMed        

  10. CAVIEDES I, Soto R, Torres A
    Pulmonary Angiopathy in Severe COVID-19: Physiological Conclusions Derived from Ventilatory Ratio?
    Am J Respir Crit Care Med. 2020 Oct 21. doi: 10.1164/rccm.202009-3446.
    PubMed        

  11. ECHTERNACH M, Gantner S, Peters G, Westphalen C, et al
    Impulse Dispersion of Aerosols During Singing and Speaking: A Potential COVID-19 Transmission Pathway.
    Am J Respir Crit Care Med. 2020 Oct 16. doi: 10.1164/rccm.202009-3438.
    PubMed        

  12. BATARSEH E, Kersten BP, Pinelo AC, Nadler JN, et al
    Angioedema in African Americans Patients Hospitalized for COVID-19.
    Am J Respir Crit Care Med. 2020 Oct 14. doi: 10.1164/rccm.202006-2223.
    PubMed        

  13. PERIER F, Tuffet S, Maraffi T, Alcala G, et al
    Effect of PEEP and Proning on Ventilation and Perfusion in COVID-19 ARDS.
    Am J Respir Crit Care Med. 2020 Oct 19. doi: 10.1164/rccm.202008-3058.
    PubMed        

  14. GATTINONI L, Marini JJ, Camporota L
    Reply to: Respiratory Drive Measurements do not Signify Conjectural P-SILI.
    Am J Respir Crit Care Med. 2020 Oct 16. doi: 10.1164/rccm.202009-3692.
    PubMed        

  15. TOBIN MJ, Jubran A, Laghi F
    Respiratory Drive Measurements do not Signify Conjectural P-SILI.
    Am J Respir Crit Care Med. 2020 Oct 16. doi: 10.1164/rccm.202009-3630.
    PubMed        


    Ann Intern Med

  16. SRINIVASAN M, Asch S, Vilendrer S, Thomas SC, et al
    Qualitative Assessment of Rapid System Transformation to Primary Care Video Visits at an Academic Medical Center.
    Ann Intern Med. 2020;173:527-535.
    PubMed         Abstract available

  17. WEISSMAN GE, Crane-Droesch A, Chivers C, Mikkelsen ME, et al
    Locally Informed Simulation to Predict Hospital Capacity Needs During the COVID-19 Pandemic.
    Ann Intern Med. 2020;173:680-681.
    PubMed        

  18. CLIFT AK, Coupland CAC, Keogh RH, Hemingway H, et al
    COVID-19 Mortality Risk in Down Syndrome: Results From a Cohort Study Of 8 Million Adults.
    Ann Intern Med. 2020 Oct 21. doi: 10.7326/M20-4986.
    PubMed        

  19. STERN RH
    Locally Informed Simulation to Predict Hospital Capacity Needs During the COVID-19 Pandemic.
    Ann Intern Med. 2020;173:679-680.
    PubMed        

  20. SACKS HS
    Accuracy of point-of-care diagnostic tests for SARS-CoV-2 antibodies (IgM/IgG) is heterogeneous.
    Ann Intern Med. 2020;173:JC47.
    PubMed         Abstract available

  21. SINGH A, Sonpar A
    In adults exposed to COVID-19, hydroxychloroquine did not reduce confirmed or probable COVID-19; trial stopped for futility.
    Ann Intern Med. 2020;173:JC41.
    PubMed         Abstract available


  22. Correction: Infection Fatality Ratios for COVID-19 Among Noninstitutionalized Persons 12 and Older.
    Ann Intern Med. 2020;173:684.
    PubMed        

  23. LO B, Sim I
    Ethical Framework for Assessing Manual and Digital Contact Tracing for COVID-19.
    Ann Intern Med. 2020 Oct 20. doi: 10.7326/M20-5834.
    PubMed         Abstract available

  24. CHOU R, Dana T, Buckley DI, Selph S, et al
    Update Alert 5: Epidemiology of and Risk Factors for Coronavirus Infection in Health Care Workers.
    Ann Intern Med. 2020 Oct 20. doi: 10.7326/L20-1227.
    PubMed        

  25. MEHROTRA DV, Janes HE, Fleming TR, Annunziato PW, et al
    Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials.
    Ann Intern Med. 2020 Oct 22. doi: 10.7326/M20-6169.
    PubMed         Abstract available

  26. LAINE C, Cotton D, Moyer DV
    COVID-19 Vaccine: What Physicians Need to Know.
    Ann Intern Med. 2020 Oct 20. doi: 10.7326/M20-6841.
    PubMed        

  27. HERNANDEZ AV, Roman YM, Pasupuleti V, Barboza JJ, et al
    Update Alert 3: Hydroxychloroquine or Chloroquine for the Treatment or Prophylaxis of COVID-19.
    Ann Intern Med. 2020 Oct 21. doi: 10.7326/L20-1257.
    PubMed        


    Antiviral Res

  28. CHOI SW, Shin JS, Park SJ, Jung E, et al
    Antiviral activity and safety of remdesivir against SARS-CoV-2 infection in human pluripotent stem cell-derived cardiomyocytes.
    Antiviral Res. 2020 Oct 19:104955. doi: 10.1016/j.antiviral.2020.104955.
    PubMed         Abstract available


    BMJ

  29. TAYLOR L
    Covid-19: Venezuela's doctors refuse to be gagged.
    BMJ. 2020;371:m3938.
    PubMed        

  30. NACI H, Kesselheim AS, Rottingen JA, Salanti G, et al
    Producing and using timely comparative evidence on drugs: lessons from clinical trials for covid-19.
    BMJ. 2020;371:m3869.
    PubMed        

  31. RIMMER A
    Covid-19: Extend visas for international staff to help fight second wave, health unions urge.
    BMJ. 2020;371:m4041.
    PubMed        

  32. WALSH S, Simmons-Jones F, Best R
    Care during covid-19: partner attendance at maternity services.
    BMJ. 2020;371:m3973.
    PubMed        

  33. TANNE JH
    Covid-19: Fauci awarded for "unprecedented public service" while Trump fires more insults.
    BMJ. 2020;371:m4064.
    PubMed        

  34. CAR J, Koh GC, Foong PS, Wang CJ, et al
    Video consultations in primary and specialist care during the covid-19 pandemic and beyond.
    BMJ. 2020;371:m3945.
    PubMed        

  35. MCKEE M, Stuckler D
    Scientific divisions on covid-19: not what they might seem.
    BMJ. 2020;371:m4024.
    PubMed        

  36. RIMMER A
    Increase medical workforce to tackle covid-19 backlog, doctors' leaders urge.
    BMJ. 2020;371:m4056.
    PubMed        

  37. DAVEY SMITH G, Blastland M, Munafo M
    Covid-19's known unknowns.
    BMJ. 2020;371:m3979.
    PubMed        

  38. CAESAR S, Layer G, Alexander R, Banks V, et al
    Appraisal needs to re-start now so doctors can reflect on coronavirus experiences.
    BMJ. 2020;371:m3987.
    PubMed        

  39. O'DOWD A
    Covid-19 pandemic is magnifying healthcare inequalities, says England's regulator.
    BMJ. 2020;371:m4035.
    PubMed        

  40. DYER O
    Covid-19: Remdesivir has little or no impact on survival, WHO trial shows.
    BMJ. 2020;371:m4057.
    PubMed        

  41. MAHASE E
    Covid-19: Experts recommend two week circuit break to reduce transmission in the UK.
    BMJ. 2020;371:m4038.
    PubMed        

  42. IACOBUCCI G
    Covid-19: England's test and trace system records worst weekly performance since launch.
    BMJ. 2020;371:m4027.
    PubMed        

  43. IACOBUCCI G
    Covid-19: Shielding may be reintroduced for vulnerable people in highest risk areas.
    BMJ. 2020;371:m3969.
    PubMed        

  44. IACOBUCCI G
    Covid-19: Three tier alert system takes effect across England.
    BMJ. 2020;371:m3961.
    PubMed        

  45. BUTLER M, Pollak TA, Rooney AG, Michael BD, et al
    Neuropsychiatric complications of covid-19.
    BMJ. 2020;371:m3871.
    PubMed        

  46. WISE J
    Covid-19: Leading doctors argue against local lockdowns.
    BMJ. 2020;371:m3959.
    PubMed        

  47. SPELSBERG A, Keil U
    Should we continue covid-19 suppression measures based on a transmission model that ignored pre-existing human immunity?
    BMJ. 2020;371:m3927.
    PubMed        

  48. MAHASE E
    Covid-19: Johnson and Johnson vaccine trial is paused because of unexplained illness in participant.
    BMJ. 2020;371:m3967.
    PubMed        

  49. COOMBES R
    The BMJ Interview: Tim Spector on how data can arm us against covid-19.
    BMJ. 2020;371:m3921.
    PubMed        

  50. KURTH T, Brinks R
    Predicting the pandemic.
    BMJ. 2020;371:m3932.
    PubMed        

  51. DYER O
    Covid-19: Eli Lilly pauses antibody trial for safety reasons.
    BMJ. 2020;371:m3985.
    PubMed        

  52. HAM C
    Covid-19 exposes NHS fault lines in England.
    BMJ. 2020;371:m3922.
    PubMed        

  53. LIMB M
    Covid-19: Liverpool's intensive care and critical care beds are "filling up fast," health leader warns.
    BMJ. 2020;371:m3977.
    PubMed        

  54. FORSYTH S
    Operation Moonshot: is it time to rein in the public health experts?
    BMJ. 2020;371:m3917.
    PubMed        

  55. SPENCE D
    Covid-19 in Sweden and the UK: Risk, the Game of Life.
    BMJ. 2020;371:m4068.
    PubMed        

  56. SPERRIN M, McMillan B
    Prediction models for covid-19 outcomes.
    BMJ. 2020;371:m3777.
    PubMed        

  57. SHEPHERD A
    Covid-19: Empty chairs mark US deaths.
    BMJ. 2020;371:m3949.
    PubMed        

  58. MAHASE E
    Covid-19: Vaccine trials need more transparency to enable scrutiny and earn public trust, say experts.
    BMJ. 2020;371:m4042.
    PubMed        

  59. TANNE JH
    Covid 19: Patients have many more complications than flu patients, finds US study.
    BMJ. 2020;371:m4106.
    PubMed        

  60. IACOBUCCI G
    Covid-19: Increased risk among ethnic minorities is largely due to poverty and social disparities, review finds.
    BMJ. 2020;371:m4099.
    PubMed        

  61. AGARWAL A, Mukherjee A, Kumar G, Chatterjee P, et al
    Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial).
    BMJ. 2020;371:m3939.
    PubMed         Abstract available

  62. PATHAK EB
    Convalescent plasma is ineffective for covid-19.
    BMJ. 2020;371:m4072.
    PubMed        

  63. MAHASE E
    Covid-19: Human challenge studies will see people purposefully infected with virus.
    BMJ. 2020;371:m4101.
    PubMed        

  64. RIMMER A
    Covid-19: Most trainees have faced disruption to their training, GMC survey shows.
    BMJ. 2020;371:m4093.
    PubMed        

  65. DOSHI P
    Will covid-19 vaccines save lives? Current trials aren't designed to tell us.
    BMJ. 2020;371:m4037.
    PubMed        

  66. WISE J
    Covid-19: Suicidal thoughts increased in young adults during lockdown, UK study finds.
    BMJ. 2020;371:m4095.
    PubMed        

  67. SPOONER A
    Covid-19 in Sweden and UK: medical leadership should energise wider debate.
    BMJ. 2020;371:m4066.
    PubMed        

  68. CLIFT AK, Coupland CAC, Keogh RH, Diaz-Ordaz K, et al
    Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study.
    BMJ. 2020;371:m3731.
    PubMed         Abstract available

  69. GRIFFIN S
    Covid-19: Second wave death rate is doubling fortnightly but is lower and slower than in March.
    BMJ. 2020;371:m4092.
    PubMed        

  70. MAHASE E
    Covid-19: Harshest restrictions are imposed on Greater Manchester after talks collapse.
    BMJ. 2020;371:m4084.
    PubMed        

  71. OLIVER D
    David Oliver: How not to do covid-19 comms-copy our government.
    BMJ. 2020;371:m3986.
    PubMed        

  72. SILBERNER J
    What covid-19 and health insurance mean for the US election.
    BMJ. 2020;371:m3781.
    PubMed        

  73. DOSHI P
    Covid-19 vaccine trial protocols released.
    BMJ. 2020;371:m4058.
    PubMed        


    Clin Chem

  74. SUHANDYNATA RT, Hoffman MA, Huang D, Tran JT, et al
    Commercial Serology Assays Predict Neutralization Activity Against SARS-CoV-2.
    Clin Chem. 2020 Oct 21. pii: 5934505. doi: 10.1093.
    PubMed         Abstract available


    Clin Infect Dis

  75. RODRIGUEZ JY, Le Pape P, Lopez O, Esquea K, et al
    Candida auris: a latent threat to critically ill patients with COVID-19.
    Clin Infect Dis. 2020 Oct 18. pii: 5929667. doi: 10.1093/cid/ciaa1595.
    PubMed        

  76. WHITE PL, Dhillon R, Healy B, Wise MP, et al
    Candidaemia in COVID-19, a link to disease pathology or increased clinical pressures?
    Clin Infect Dis. 2020 Oct 18. pii: 5929669. doi: 10.1093/cid/ciaa1597.
    PubMed        

  77. RAJASINGHAM R, Bangdiwala AS, Nicol MR, Skipper CP, et al
    Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trial.
    Clin Infect Dis. 2020 Oct 17. pii: 5929230. doi: 10.1093/cid/ciaa1571.
    PubMed         Abstract available

  78. LESSLER J
    An overlooked role for fecal transmission of SARS-CoV-2?
    Clin Infect Dis. 2020 Oct 16. pii: 5925219. doi: 10.1093/cid/ciaa1575.
    PubMed        

  79. MCCAW ZR, Tian L, Kim DH, Localio AR, et al
    Survival analysis of treatment efficacy in comparative COVID-19 studies.
    Clin Infect Dis. 2020 Oct 14. pii: 5923375. doi: 10.1093/cid/ciaa1563.
    PubMed         Abstract available

  80. DU P, Song C, Li R, Song Y, et al
    Specific re-distribution of SARS-CoV-2 variants in the respiratory system and intestinal tract.
    Clin Infect Dis. 2020 Oct 22. pii: 5934821. doi: 10.1093/cid/ciaa1617.
    PubMed         Abstract available

  81. SACHITHANANDHAM J, Thio CL, Balagopal A
    The Natural History of Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Composite But Incomplete Picture.
    Clin Infect Dis. 2020 Sep 29. pii: 5912956. doi: 10.1093/cid/ciaa1413.
    PubMed        

  82. ASLAM A, Singh J, Robilotti E, Chow K, et al
    SARS CoV-2 Surveillance and Exposure in the Perioperative Setting with Universal testing and Personal Protective Equipment (PPE) Policies.
    Clin Infect Dis. 2020 Oct 22. pii: 5934921. doi: 10.1093/cid/ciaa1607.
    PubMed         Abstract available

  83. OLDONI E, van Gool A, Garcia Bermejo L, Scherer A, et al
    Biomarker Research and Development for Coronavirus Disease 2019 (COVID-19): European Medical Research Infrastructures Call for Global Coordination.
    Clin Infect Dis. 2020 Oct 22. pii: 5935756. doi: 10.1093/cid/ciaa1250.
    PubMed         Abstract available

  84. CONOVER CS
    Transmission of SARS-CoV-2 via Contaminated Surfaces: What is to be Done?
    Clin Infect Dis. 2020 Oct 18. pii: 5929662. doi: 10.1093/cid/ciaa1586.
    PubMed        

  85. PIMENOFF VN, Elfstrom M, Baussano I, Bjornstedt M, et al
    Estimating total excess mortality during a COVID-19 outbreak in Stockholm, Sweden.
    Clin Infect Dis. 2020 Oct 18. pii: 5929661. doi: 10.1093/cid/ciaa1593.
    PubMed         Abstract available

  86. KOJIMA N, Turner F, Slepnev V, Bacelar A, et al
    Self-Collected Oral Fluid and Nasal Swab Specimens Demonstrate Comparable Sensitivity to Clinician-Collected Nasopharyngeal Swab Specimens for the Detection of SARS-CoV-2.
    Clin Infect Dis. 2020 Oct 19. pii: 5930814. doi: 10.1093/cid/ciaa1589.
    PubMed         Abstract available

  87. ANESI GL
    Hospital transfers across U.S. regions to address the "space" shortage in a pandemic: a public good.
    Clin Infect Dis. 2020 Oct 18. pii: 5929668. doi: 10.1093/cid/ciaa1596.
    PubMed        

  88. DAUBY N
    Favipiravir as an antiviral agent in COVID-19: same script, different cast?
    Clin Infect Dis. 2020 Oct 19. pii: 5930653. doi: 10.1093/cid/ciaa1600.
    PubMed        

  89. YANG B, Fulcher JA, Ahn J, Berro M, et al
    Clinical Characteristics and Outcomes of COVID-19 Patients Receiving Compassionate Use Leronlimab.
    Clin Infect Dis. 2020 Oct 20. pii: 5932277. doi: 10.1093/cid/ciaa1583.
    PubMed         Abstract available

  90. XU J, Teng Y, Shang L, Gu X, et al
    The Effect of Prior ACEI/ARB Treatment on COVID-19 Susceptibility and Outcome: A Systematic Review and Meta-Analysis.
    Clin Infect Dis. 2020 Oct 20. pii: 5932274. doi: 10.1093/cid/ciaa1592.
    PubMed         Abstract available

  91. O'DRISCOLL M, Harry C, Donnelly CA, Cori A, et al
    A comparative analysis of statistical methods to estimate the reproduction number in emerging epidemics with implications for the current COVID-19 pandemic.
    Clin Infect Dis. 2020 Oct 20. pii: 5932264. doi: 10.1093/cid/ciaa1599.
    PubMed         Abstract available

  92. LEI H, Wu X, Wang X, Xu M, et al
    Different transmission dynamics of COVID-19 and influenza suggest the relative efficiency of isolation/quarantine and social distancing against COVID-19 in China.
    Clin Infect Dis. 2020 Oct 20. pii: 5932276. doi: 10.1093/cid/ciaa1584.
    PubMed         Abstract available

  93. AZZI L
    Saliva is the Key Element for SARS-CoV-2 Mass Screening.
    Clin Infect Dis. 2020 Oct 21. pii: 5933821. doi: 10.1093/cid/ciaa1440.
    PubMed        

  94. AHMAD MF, Mahakkanukrauh P, Das S
    The detection of SARS-CoV-2 virus in the vaginal fluid of females with severe COVID-19 infection: scientific facts.
    Clin Infect Dis. 2020 Oct 21. pii: 5934738. doi: 10.1093/cid/ciaa1608.
    PubMed        

  95. GERETTI AM, Stockdale AJ, Kelly SH, Cevik M, et al
    Outcomes of COVID-19 related hospitalization among people with HIV in the ISARIC WHO Clinical Characterization Protocol (UK): a prospective observational study.
    Clin Infect Dis. 2020 Oct 23. pii: 5937133. doi: 10.1093/cid/ciaa1605.
    PubMed         Abstract available

  96. YOSHIOKA T, Funada S, Luo Y
    The inherent problems with the generalizability of the CALL score: towards reliable clinical prediction models for COVID-19.
    Clin Infect Dis. 2020 Oct 16. pii: 5925185. doi: 10.1093/cid/ciaa1564.
    PubMed        


    Emerg Infect Dis

  97. JOSEPH NT, Stanhope KK, Badell ML, Horton JP, et al
    Sociodemographic Predictors of SARS-CoV-2 Infection in Obstetric Patients, Georgia, USA.
    Emerg Infect Dis. 2020;26:2787-2789.
    PubMed         Abstract available

  98. CHAU NVV, Hong NTT, Ngoc NM, Thanh TT, et al
    Superspreading Event of SARS-CoV-2 Infection at a Bar, Ho Chi Minh City, Vietnam.
    Emerg Infect Dis. 2020;27.
    PubMed         Abstract available

  99. WALTENBURG MA, Rose CE, Victoroff T, Butterfield M, et al
    Coronavirus Disease among Workers in Food Processing, Food Manufacturing, and Agriculture Workplaces.
    Emerg Infect Dis. 2020;27.
    PubMed         Abstract available

  100. GUZZETTA G, Riccardo F, Marziano V, Poletti P, et al
    Impact of a Nationwide Lockdown on SARS-CoV-2 Transmissibility, Italy.
    Emerg Infect Dis. 2020;27.
    PubMed         Abstract available

  101. MARR KA, Platt A, Tornheim JA, Zhang SX, et al
    Aspergillosis Complicating Severe Coronavirus Disease.
    Emerg Infect Dis. 2020;27.
    PubMed         Abstract available

  102. SCHWARZKOPF S, Krawczyk A, Knop D, Klump H, et al
    Cellular Immunity in COVID-19 Convalescents with PCR-Confirmed Infection but with Undetectable SARS-CoV-2-Specific IgG.
    Emerg Infect Dis. 2020;27.
    PubMed         Abstract available

  103. FREULING CM, Breithaupt A, Muller T, Sehl J, et al
    Susceptibility of Raccoon Dogs for Experimental SARS-CoV-2 Infection.
    Emerg Infect Dis. 2020;26.
    PubMed         Abstract available

  104. DIA N, Lakh NA, Diagne MM, Mbaye KD, et al
    COVID-19 Outbreak, Senegal, 2020.
    Emerg Infect Dis. 2020;26:2772-2774.
    PubMed         Abstract available

  105. CHOE PG, Kang CK, Suh HJ, Jung J, et al
    Waning Antibody Responses in Asymptomatic and Symptomatic SARS-CoV-2 Infection.
    Emerg Infect Dis. 2020;27.
    PubMed         Abstract available

  106. CHAN PKS, Lui G, Hachim A, Ko RLW, et al
    Serologic Responses in Healthy Adult with SARS-CoV-2 Reinfection, Hong Kong, August 2020.
    Emerg Infect Dis. 2020;26.
    PubMed         Abstract available


    Eur J Radiol

  107. YU T
    COV is a readily available quantitative indicator of metabolic heterogeneity for predicting survival of patients with early and locally advanced NSCLC manifesting as central lung cancer.
    Eur J Radiol. 2020;132:109338.
    PubMed         Abstract available

  108. OOI MWX, Rajai A, Patel R, Gerova N, et al
    Pulmonary thromboembolic disease in COVID-19 patients on CT pulmonary angiography - Prevalence, pattern of disease and relationship to D-dimer.
    Eur J Radiol. 2020;132:109336.
    PubMed         Abstract available

  109. COLOMBI D, Petrini M, Maffi G, Villani GD, et al
    Comparison of admission chest computed tomography and lung ultrasound performance for diagnosis of COVID-19 pneumonia in populations with different disease prevalence.
    Eur J Radiol. 2020;133:109344.
    PubMed         Abstract available


    Infect Control Hosp Epidemiol

  110. DIERINGER TD, Furukawa D, Graber CJ, Stevens VW, et al
    Inpatient antibiotic utilization in the Veterans Administration during the COVID-19 pandemic.
    Infect Control Hosp Epidemiol. 2020 Oct 20:1-9. doi: 10.1017/ice.2020.1277.
    PubMed         Abstract available

  111. MENA LORA AJ, Ali M, Krill C, Borgetti SA, et al
    Feasibility and impact of inverted classroom methodology for COVID-19 pandemic preparedness at an urban community hospital.
    Infect Control Hosp Epidemiol. 2020 Oct 20:1-9. doi: 10.1017/ice.2020.1272.
    PubMed        

  112. MILLER J, Opat S, Shortt J, Kotsanas D, et al
    Impact of COVID-19 Pandemic Isolation Measures on the Rate of Non-COVID Infections in Hematology Patients.
    Infect Control Hosp Epidemiol. 2020 Oct 20:1-10. doi: 10.1017/ice.2020.1279.
    PubMed        

  113. FONTANA L, Villamagna AH, Sikka MK, McGregor JC, et al
    Understanding Viral Shedding of SARS-CoV-2: Review of Current Literature.
    Infect Control Hosp Epidemiol. 2020 Oct 20:1-35. doi: 10.1017/ice.2020.1273.
    PubMed         Abstract available

  114. ONG SWX, Lee PH, Tan YK, Ling LM, et al
    Environmental contamination in a COVID-19 intensive care unit (ICU) - what is the risk?
    Infect Control Hosp Epidemiol. 2020 Oct 21:1-28. doi: 10.1017/ice.2020.1278.
    PubMed         Abstract available

  115. MURTHY AR, Hanrahan JA, Advani SD, Ashraf MS, et al
    State of the Pandemic Commentary: Preparing Nursing Homes for a Second Wave of COVID-19.
    Infect Control Hosp Epidemiol. 2020 Oct 20:1-9. doi: 10.1017/ice.2020.1283.
    PubMed        


    Int J Infect Dis

  116. MALVIYA A
    The continued dilemma about the usage of hydroxychloroquine: Respite is in randomized control trials.
    Int J Infect Dis. 2020;99:310-311.
    PubMed        

  117. MADSEN LW, Lindvig SO, Rasmussen LD, Knudtzen FC, et al
    Low mortality of hospitalised patients with COVID-19 in a tertiary Danish hospital setting.
    Int J Infect Dis. 2020 Oct 12. pii: S1201-9712(20)32221.
    PubMed         Abstract available

  118. MOHANA A, Sulaiman T, Mahmoud N, Hassanein M, et al
    Hydroxychloroquine Safety Outcome within Approved Therapeutic Protocol for COVID-19 Outpatients in Saudi Arabia.
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32235.
    PubMed         Abstract available

  119. NG CFS, Seposo XT, Moi ML, Tajudin MABA, et al
    Characteristics of COVID-19 epidemic and control measures to curb transmission in Malaysia.
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32231.
    PubMed         Abstract available

  120. STAADEGAARD L, Taylor RJ, Spreeuwenberg P, Caini S, et al
    Monitoring the mortality impact of COVID-19 in Europe: What can be learned from 2009 influenza H1N1p mortality studies?
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32241.
    PubMed         Abstract available

  121. DAUBY N, Bottieau E
    The unfinished story of hydroxychloroquine in COVID-19: the right anti-inflammatory dose at the right moment?
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32236.
    PubMed        

  122. BAECK M, Herman A
    COVID toes: where do we stand with the current evidence?
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32225.
    PubMed         Abstract available

  123. MOHAMMAD A, Alshawaf E, Marafie SK, Abu-Farha M, et al
    Higher binding affinity of Furin to SARS-CoV-2 spike (S) protein D614G could be associated with higher SARS-CoV-2 infectivity.
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32237.
    PubMed         Abstract available

  124. ABAYOMI A, Odukoya O, Osibogun A, Wright O, et al
    Presenting Symptoms and Predictors of Poor Outcomes Among 2,184 Patients with COVID-19 in Lagos State, Nigeria.
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32228.
    PubMed         Abstract available

  125. LAWAL Y
    Africa's low COVID-19 mortality rate: A paradox?
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32242.
    PubMed         Abstract available

  126. HERZBERG J, Vollmer T, Fischer B, Becher H, et al
    A Prospective Sero-epidemiological Evaluation of SARS-CoV-2 among Health Care Workers in a German Secondary Care Hospital.
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32230.
    PubMed         Abstract available

  127. VELAVAN TP, Meyer CG
    Reply to: Asymptomatic infection by SARS 2 coronavirus: invisible but invincible.
    Int J Infect Dis. 2020 Oct 17. pii: S1201-9712(20)32238.
    PubMed        

  128. VENUGOPAL U, Jilani N, Rabah S, Shariff MA, et al
    SARS-CoV-2 Seroprevalence Among Health Care Workers in a New York City Hospital: A Cross-Sectional Analysis During the COVID-19 Pandemic.
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32240.
    PubMed         Abstract available

  129. NAKAMOTO T, Ishikane M, Sasaki R, Ohmagari N, et al
    Periungual desquamation in a Japanese Adult recovering from severe COVID-19.
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32233.
    PubMed         Abstract available


    Intensive Care Med


  130. Differences in clinical deterioration among three sub-phenotypes of COVID-19 patients at the time of first positive test: results from a clustering analysis.
    Intensive Care Med. 2020 Oct 19. pii: 10.1007/s00134-020-06236.
    PubMed        

  131. DE WAELE JJ, Derde L, Bassetti M
    Antimicrobial stewardship in ICUs during the COVID-19 pandemic: back to the 90s?
    Intensive Care Med. 2020 Oct 17. pii: 10.1007/s00134-020-06278.
    PubMed        

  132. DE JONG A, Wrigge H, Hedenstierna G, Gattinoni L, et al
    How to ventilate obese patients in the ICU.
    Intensive Care Med. 2020 Oct 23. pii: 10.1007/s00134-020-06286.
    PubMed         Abstract available

  133. CHIUMELLO D, Busana M, Coppola S, Romitti F, et al
    Physiological and quantitative CT-scan characterization of COVID-19 and typical ARDS: a matched cohort study.
    Intensive Care Med. 2020 Oct 21. pii: 10.1007/s00134-020-06281.
    PubMed         Abstract available

  134. CARTER MJ, Shankar-Hari M, Tibby SM
    Paediatric Inflammatory Multisystem Syndrome Temporally-Associated with SARS-CoV-2 Infection: An Overview.
    Intensive Care Med. 2020 Oct 14. pii: 10.1007/s00134-020-06273.
    PubMed        


    J Infect

  135. WELLS PM, Doores KJ, Couvreur S, Nunez RM, et al
    Estimates of the rate of infection and asymptomatic COVID-19 disease in a population sample from SE England.
    J Infect. 2020 Oct 14. pii: S0163-4453(20)30653.
    PubMed         Abstract available


    J Med Virol

  136. WU S, Tian C, Liu P, Guo D, et al
    Effects of SARS-CoV-2 mutations on protein structures and intraviral protein-protein interactions.
    J Med Virol. 2020 Oct 14. doi: 10.1002/jmv.26597.
    PubMed         Abstract available

  137. ROSEN HR, O'Connell C, Nadim MK, DeClerck B, et al
    Extrapulmonary Manifestations of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Infection.
    J Med Virol. 2020 Oct 14. doi: 10.1002/jmv.26595.
    PubMed         Abstract available

  138. SREENIVASAN CC, Thomas M, Wang D, Li F, et al
    Susceptibility of livestock and companion animals to COVID-19.
    J Med Virol. 2020 Oct 22. doi: 10.1002/jmv.26621.
    PubMed         Abstract available

  139. TAKAGI H
    Presidential vote 2016 and COVID-19 epidemic.
    J Med Virol. 2020 Oct 22. doi: 10.1002/jmv.26620.
    PubMed         Abstract available

  140. BWIRE GM, Njiro BJ, Mwakawanga DL, Sabas D, et al
    Possible vertical transmission and antibodies against SARS-CoV-2 among infants born to mothers with COVID-19: A living systematic review.
    J Med Virol. 2020 Oct 22. doi: 10.1002/jmv.26622.
    PubMed         Abstract available

  141. HE J, Huang F, Zhang J, Chen Q, et al
    Vaccine design based on 16 epitopes of SARS-CoV-2 spike protein.
    J Med Virol. 2020 Oct 14. doi: 10.1002/jmv.26596.
    PubMed         Abstract available

  142. SHAMINUR RAHMAN M, Rafiul Islam M, Rubayet Ul Alam ASM, Islam I, et al
    Evolutionary dynamics of SARS-CoV-2 nucleocapsid (N) protein and its consequences.
    J Med Virol. 2020 Oct 23. doi: 10.1002/jmv.26626.
    PubMed         Abstract available

  143. BAIG AM
    Chronic COVID Syndrome: Need for an appropriate medical terminology for Long-COVID and COVID Long-Haulers.
    J Med Virol. 2020 Oct 23. doi: 10.1002/jmv.26624.
    PubMed         Abstract available

  144. WANG Y, Chen B, Li Y, Zhang L, et al
    The Use of Renin-Angiotensin-Aldosterone System (RAAS) Inhibitors is Associated with a Lower Risk of Mortality in Hypertensive COVID-19 Patients: A Systematic Review and Meta-analysis.
    J Med Virol. 2020 Oct 23. doi: 10.1002/jmv.26625.
    PubMed         Abstract available

  145. HIGUCHI T, Nishida T, Iwahashi H, Morimura O, et al
    Early Clinical Factors Predicting the Development of Critical Disease in Japanese Patients with COVID-19: A Single-Center, Retrospective, Observational Study.
    J Med Virol. 2020 Oct 14. doi: 10.1002/jmv.26599.
    PubMed         Abstract available

  146. MOHANTY S, Ravindra A, Gupta K, Hallur V, et al
    Intricacies in characterizing positivity in pooled sample testing for SARS-CoV-2.
    J Med Virol. 2020 Oct 21. doi: 10.1002/jmv.26618.
    PubMed         Abstract available

  147. CHEN Y, Ke Y, Liu X, Wang Z, et al
    Clinical features and antibody response of patients from a COVID-19 treatment hospital in Wuhan, China.
    J Med Virol. 2020 Oct 21. doi: 10.1002/jmv.26617.
    PubMed         Abstract available

  148. YAZDANPANAH Y
    Impact on disease mortality of clinical, biological and virological characteristics at hospital admission and over time in COVID-19 patients.
    J Med Virol. 2020 Oct 15. doi: 10.1002/jmv.26601.
    PubMed         Abstract available

  149. SILVA JUNIOR JVJ, Lopes TRR, Weiblen R, Flores EF, et al
    Background immunity: how important is it for SARS-CoV-2?
    J Med Virol. 2020 Oct 15. doi: 10.1002/jmv.26602.
    PubMed         Abstract available

  150. YIGENOGLU TN, Basci S, Sinan Dal M, Korkmaz S, et al
    The outcome of COVID-19 in patients with hematological malignancy.
    J Med Virol. 2020 Oct 16. doi: 10.1002/jmv.26607.
    PubMed         Abstract available

  151. CRISCUOLO E, Diotti RA, Strollo M, Rolla S, et al
    Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects.
    J Med Virol. 2020 Oct 16. doi: 10.1002/jmv.26605.
    PubMed         Abstract available

  152. STRATTON CW, Tang YW, Lu H
    Pathogenesis-Directed Therapy of 2019 Novel Coronavirus Disease.
    J Med Virol. 2020 Oct 19. doi: 10.1002/jmv.26610.
    PubMed         Abstract available

  153. YANG P, Wang N, Wang J, Luo A, et al
    Admission fasting plasma glucose is an independent risk factor for 28-day mortality in patients with COVID-19.
    J Med Virol. 2020 Oct 19. doi: 10.1002/jmv.26608.
    PubMed         Abstract available

  154. CAVALIERE AF, Marchi L, Aquilini D, Brunelli T, et al
    Passive Immunity in Newborn from SARS-CoV-2 Infected Mother.
    J Med Virol. 2020 Oct 19. doi: 10.1002/jmv.26609.
    PubMed         Abstract available

  155. YUN HE, Ryu BY, Choe YJ
    Impact of Social Distancing on Incidence of Vaccine-Preventable Diseases, South Korea.
    J Med Virol. 2020 Oct 20. doi: 10.1002/jmv.26614.
    PubMed         Abstract available

  156. SELINGEROVA I, Valik D, Gescheidtova L, Sramek V, et al
    Interpretive discrepancies caused by target values inter-batch variations in chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG by MAGLUMI.
    J Med Virol. 2020 Oct 20. doi: 10.1002/jmv.26612.
    PubMed         Abstract available

  157. KIVELA JM, Jarva H, Lappalainen M, Kurkela S, et al
    Saliva-based testing for diagnosis of SARS-CoV-2 infection: A meta-analysis.
    J Med Virol. 2020 Oct 20. doi: 10.1002/jmv.26613.
    PubMed         Abstract available

  158. KUMAR A, Prasoon P, Kumari C, Pareek V, et al
    SARS-CoV-2 specific virulence factors in COVID-19.
    J Med Virol. 2020 Oct 21. doi: 10.1002/jmv.26615.
    PubMed         Abstract available

  159. MATTOS EC, Matsuda EM, Colpas DR, Carvalho F, et al
    Can urine be a potential biohazard in times of SARS-CoV-2 pandemic?
    J Med Virol. 2020 Oct 21. doi: 10.1002/jmv.26616.
    PubMed         Abstract available

  160. PODDER S, Ghosh A, Ghosh T
    Mutations in membrane-fusion subunit of spike glycoprotein play crucial role in the recent outbreak of COVID-19.
    J Med Virol. 2020 Oct 14. doi: 10.1002/jmv.26598.
    PubMed         Abstract available


    J Thorac Oncol

  161. KIDANE B, Levin DP
    Identification and Resolution of Asymptomatic COVID-19 Pneumonitis and Colitis: Serial Assessment of Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography for Evaluation of Lung Cancer.
    J Thorac Oncol. 2020 Oct 5. pii: S1556-0864(20)30725.
    PubMed        


    J Travel Med

  162. CHU IY, Alam P, Larson H, Lin L, et al
    Social consequences of mass quarantine during epidemics: a systematic review with implications for the COVID-19 response.
    J Travel Med. 2020 Oct 13. pii: 5922349. doi: 10.1093.
    PubMed         Abstract available

  163. WENG CH, Chan PA
    BCG as an adjunct or alternative vaccine to prevent COVID-19?
    J Travel Med. 2020 Sep 19. pii: 5908817. doi: 10.1093.
    PubMed        

  164. YANG J, Li J, Lai S, Ruktanonchai CW, et al
    Uncovering two phases of early intercontinental COVID-19 transmission dynamics.
    J Travel Med. 2020 Oct 22. pii: 5935386. doi: 10.1093.
    PubMed         Abstract available

  165. AFEK A, Leshem E, Kaliner E, Fast D, et al
    Upholding democracy in a global pandemic: the Israeli elections experience.
    J Travel Med. 2020 Sep 15. pii: 5905946. doi: 10.1093.
    PubMed        


    J Virol

  166. MATSUYAMA S, Kawase M, Nao N, Shirato K, et al
    The inhaled steroid ciclesonide blocks SARS-CoV-2 RNA replication by targeting the viral replication-transcription complex in cultured cells.
    J Virol. 2020 Oct 14. pii: JVI.01648-20. doi: 10.1128/JVI.01648.
    PubMed         Abstract available


    JAMA

  167. ANGUS DC
    Optimizing the Trade-off Between Learning and Doing in a Pandemic.
    JAMA. 2020;323:1895-1896.
    PubMed        

  168. SARPATWARI A, Kaltenboeck A, Kesselheim AS
    Missed Opportunities on Emergency Remdesivir Use.
    JAMA. 2020;324:331-332.
    PubMed        

  169. CHWISTEK M
    "Are You Wearing Your White Coat?": Telemedicine in the Time of Pandemic.
    JAMA. 2020;324:149-150.
    PubMed        

  170. MARKS PW, Hahn S
    Identifying the Risks of Unproven Regenerative Medicine Therapies.
    JAMA. 2020;324:241-242.
    PubMed        

  171. SERAFEIM G, Rischbieth AM, Koh HK
    Sustainability, Business, and Health.
    JAMA. 2020;324:147-148.
    PubMed        

  172. LEE GM, Bell BP, Romero JR
    The Advisory Committee on Immunization Practices and Its Role in the Pandemic Vaccine Response.
    JAMA. 2020 Jul 22. pii: 2768852. doi: 10.1001/jama.2020.13167.
    PubMed        

  173. CUTLER D
    New Rules for the Pandemic Era.
    JAMA. 2020;324:1023-1024.
    PubMed        

  174. WOLINETZ CD, Collins FS
    Recognition of Research Participants' Need for Autonomy: Remembering the Legacy of Henrietta Lacks.
    JAMA. 2020;324:1027-1028.
    PubMed        

  175. ABBASI J
    Portable MRI-Coming to the ICU?
    JAMA. 2020;324:1386.
    PubMed        

  176. LEVITT L
    Trump vs Biden on Health Care.
    JAMA. 2020;324:1384-1385.
    PubMed        

  177. SAAG MS, Gandhi RT, Hoy JF, Landovitz RJ, et al
    Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society-USA Panel.
    JAMA. 2020 Oct 14. pii: 2771873. doi: 10.1001/jama.2020.17025.
    PubMed         Abstract available

  178. SCHMIDT H, Gostin LO, Williams MA
    Is It Lawful and Ethical to Prioritize Racial Minorities for COVID-19 Vaccines?
    JAMA. 2020 Oct 14. pii: 2771874. doi: 10.1001/jama.2020.20571.
    PubMed        

  179. ABBASI J
    Large Meta-analysis Digs Into Obesity's COVID-19 Risks.
    JAMA. 2020 Oct 15. pii: 2772071. doi: 10.1001/jama.2020.18637.
    PubMed        

  180. SEYMOUR CW, McCreary EK, Stegenga J
    Sensible Medicine-Balancing Intervention and Inaction During the COVID-19 Pandemic.
    JAMA. 2020 Oct 15. pii: 2772072. doi: 10.1001/jama.2020.20271.
    PubMed        

  181. VOLPP KG, Diamond SM, Shrank WH
    Innovation in Home Care: Time for a New Payment Model.
    JAMA. 2020;323:2474-2475.
    PubMed        

  182. HUYNH PP, Ishii LE, Ishii M
    What Is Anosmia?
    JAMA. 2020;324:206.
    PubMed        

  183. MCCORMACK G, Avery C, Spitzer AK, Chandra A, et al
    Economic Vulnerability of Households With Essential Workers.
    JAMA. 2020;324:388-390.
    PubMed        

  184. OWEN WF JR, Carmona R, Pomeroy C
    Failing Another National Stress Test on Health Disparities.
    JAMA. 2020;323:1905-1906.
    PubMed        

  185. FELDMAN O, Meir M, Shavit D, Idelman R, et al
    Exposure to a Surrogate Measure of Contamination From Simulated Patients by Emergency Department Personnel Wearing Personal Protective Equipment.
    JAMA. 2020;323:2091-2093.
    PubMed        

  186. THRONSON R
    Lost Space.
    JAMA. 2020;323:2019-2020.
    PubMed        

  187. BERWICK DM
    Choices for the "New Normal".
    JAMA. 2020;323:2125-2126.
    PubMed        

  188. LIVINGSTON EH
    Surgery in a Time of Uncertainty: A Need for Universal Respiratory Precautions in the Operating Room.
    JAMA. 2020;323:2254-2255.
    PubMed        

  189. ISON MG, Wolfe C, Boucher HW
    Emergency Use Authorization of Remdesivir: The Need for a Transparent Distribution Process.
    JAMA. 2020;323:2365-2366.
    PubMed        

  190. BUNYAVANICH S, Do A, Vicencio A
    Nasal Gene Expression of Angiotensin-Converting Enzyme 2 in Children and Adults.
    JAMA. 2020;323:2427-2429.
    PubMed        

  191. TOLLES J, Luong T
    Modeling Epidemics With Compartmental Models.
    JAMA. 2020;323:2515-2516.
    PubMed        

  192. RODRIGUEZ JA, Clark CR, Bates DW
    Digital Health Equity as a Necessity in the 21st Century Cures Act Era.
    JAMA. 2020;323:2381-2382.
    PubMed        

  193. SONG Z
    Potential Implications of Lowering the Medicare Eligibility Age to 60.
    JAMA. 2020;323:2472-2473.
    PubMed        

  194. SHARFSTEIN JM, Morphew CC
    The Urgency and Challenge of Opening K-12 Schools in the Fall of 2020.
    JAMA. 2020;324:133-134.
    PubMed        

  195. DESAI AN
    Artificial Intelligence: Promise, Pitfalls, and Perspective.
    JAMA. 2020;323:2448-2449.
    PubMed        

  196. RUBIN R
    COVID-19's Crushing Effects on Medical Practices, Some of Which Might Not Survive.
    JAMA. 2020;324:321-323.
    PubMed        

  197. PATEL MM, Jackson ML, Ferdinands J
    Postlicensure Evaluation of COVID-19 Vaccines.
    JAMA. 2020 Oct 16. pii: 2772136. doi: 10.1001/jama.2020.19328.
    PubMed        

  198. GOODMAN JL, Grabenstein JD, Braun MM
    Answering Key Questions About COVID-19 Vaccines.
    JAMA. 2020 Oct 16. pii: 2772138. doi: 10.1001/jama.2020.20590.
    PubMed        

  199. SHACHAR C, Engel J, Elwyn G
    Implications for Telehealth in a Postpandemic Future: Regulatory and Privacy Issues.
    JAMA. 2020;323:2375-2376.
    PubMed        

  200. BELL BP, Romero JR, Lee GM
    Scientific and Ethical Principles Underlying Recommendations From the Advisory Committee on Immunization Practices for COVID-19 Vaccination Implementation.
    JAMA. 2020 Oct 22. pii: 2772326. doi: 10.1001/jama.2020.20847.
    PubMed        

  201. RUBIN R
    The Challenges of Expanding Rapid Tests to Curb COVID-19.
    JAMA. 2020 Oct 21. pii: 2772299. doi: 10.1001/jama.2020.21106.
    PubMed        

  202. KUEHN BM
    COVID-19 Halts Reproductive Care for Millions of Women.
    JAMA. 2020;324:1489.
    PubMed        

  203. OMER SB, Yildirim I, Forman HP
    Herd Immunity and Implications for SARS-CoV-2 Control.
    JAMA. 2020 Oct 19. pii: 2772167. doi: 10.1001/jama.2020.20892.
    PubMed        

  204. LEE GM, Romero JR, Bell BP
    Postapproval Vaccine Safety Surveillance for COVID-19 Vaccines in the US.
    JAMA. 2020 Oct 16. pii: 2772137. doi: 10.1001/jama.2020.19692.
    PubMed        


    Lancet

  205. ALLOTEY P, Denton F
    Challenges and priorities for delivering on the Beijing Declaration and Platform for Action 25 years on.
    Lancet. 2020;396:1053-1055.
    PubMed        

  206. FRUMKIN H, Myers SS
    Planetary health and the 2020 US election.
    Lancet. 2020;396:1048-1050.
    PubMed        

  207. THE LANCET
    Mental health: time to invest in quality.
    Lancet. 2020;396:1045.
    PubMed        

  208. HONIGSBAUM M, Krishnan L
    Taking pandemic sequelae seriously: from the Russian influenza to COVID-19 long-haulers.
    Lancet. 2020 Oct 12. pii: S0140-6736(20)32134.
    PubMed        

  209. POLAND GA, Ovsyannikova IG, Kennedy RB
    SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates.
    Lancet. 2020 Oct 13. pii: S0140-6736(20)32137.
    PubMed         Abstract available

  210. USUELLI M
    The Lombardy region of Italy launches the first investigative COVID-19 commission.
    Lancet. 2020 Oct 15. pii: S0140-6736(20)32154.
    PubMed        

  211. PETO J, Hunter DJ, Riboli E, Griffin JL, et al
    Unnecessary obstacles to COVID-19 mass testing.
    Lancet. 2020 Oct 16. pii: S0140-6736(20)32170.
    PubMed        

  212. PAES-SOUSA R, Millett C, Rocha R, Barreto ML, et al
    Science misuse and polarised political narratives in the COVID-19 response.
    Lancet. 2020 Oct 19. pii: S0140-6736(20)32168.
    PubMed        

  213. FERIGATO S, Fernandez M, Amorim M, Ambrogi I, et al
    The Brazilian Government's mistakes in responding to the COVID-19 pandemic.
    Lancet. 2020 Oct 20. pii: S0140-6736(20)32164.
    PubMed        

  214. STEWART R, El-Harakeh A, Cherian SA
    Evidence synthesis communities in low-income and middle-income countries and the COVID-19 response.
    Lancet. 2020 Oct 20. pii: S0140-6736(20)32141.
    PubMed        

  215. ALWAN NA, Burgess RA, Ashworth S, Beale R, et al
    Scientific consensus on the COVID-19 pandemic: we need to act now.
    Lancet. 2020 Oct 15. pii: S0140-6736(20)32153.
    PubMed        


    Lancet Child Adolesc Health

  216. SWAIN K
    Coping with more than COVID-19.
    Lancet Child Adolesc Health. 2020;4:806.
    PubMed        


    Lancet Glob Health

  217. MANABE YC, Mashalla Y, Farquhar C, Sewankambo NK, et al
    Leadership training to accelerate progress in public health in sub-Saharan Africa: time for action.
    Lancet Glob Health. 2020;8:e1253-e1254.
    PubMed        

  218. KEDDY KH, Migliori GB, Van Der Walt M
    Developing health policies in patients presenting with SARS-CoV-2: consider tuberculosis.
    Lancet Glob Health. 2020;8:e1357-e1358.
    PubMed        

  219. ORESKOVIC T
    Violations of independence: ethnicity and COVID-19 in Brazil.
    Lancet Glob Health. 2020 Oct 16. pii: S2214-109X(20)30431.
    PubMed        

  220. RAKOTOSAMIMANANA N, Randrianirina F, Randremanana R, Raherison MS, et al
    GeneXpert for the diagnosis of COVID-19 in LMICs.
    Lancet Glob Health. 2020 Oct 19. pii: S2214-109X(20)30428.
    PubMed        


    Lancet Infect Dis

  221. ISAKOVA-SIVAK I, Rudenko L
    A promising inactivated whole-virion SARS-CoV-2 vaccine.
    Lancet Infect Dis. 2020 Oct 15. pii: S1473-3099(20)30832.
    PubMed        

  222. IWASAKI A
    What reinfections mean for COVID-19.
    Lancet Infect Dis. 2020 Oct 12. pii: S1473-3099(20)30783.
    PubMed        

  223. TILLETT RL, Sevinsky JR, Hartley PD, Kerwin H, et al
    Genomic evidence for reinfection with SARS-CoV-2: a case study.
    Lancet Infect Dis. 2020 Oct 12. pii: S1473-3099(20)30764.
    PubMed         Abstract available

  224. XIA S, Zhang Y, Wang Y, Wang H, et al
    Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial.
    Lancet Infect Dis. 2020 Oct 15. pii: S1473-3099(20)30831.
    PubMed         Abstract available

  225. BROWN RCH, Kelly D, Wilkinson D, Savulescu J, et al
    The scientific and ethical feasibility of immunity passports.
    Lancet Infect Dis. 2020 Oct 16. pii: S1473-3099(20)30766.
    PubMed         Abstract available

  226. YANG W, Kandula S, Huynh M, Greene SK, et al
    Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-based analysis.
    Lancet Infect Dis. 2020 Oct 19. pii: S1473-3099(20)30769.
    PubMed         Abstract available


    Lancet Psychiatry

  227. OLDHAM MA, Slooter AJC, Cunningham C, Rahman S, et al
    Characterising neuropsychiatric disorders in patients with COVID-19.
    Lancet Psychiatry. 2020;7:932-933.
    PubMed        

  228. VARATHARAJ A, Pollak TA, Nicholson TR, Coles JP, et al
    Characterising neuropsychiatric disorders in patients with COVID-19 - Authors' reply.
    Lancet Psychiatry. 2020;7:934-935.
    PubMed        

  229. WADE D, Howell D, Beadman M, Quigley A, et al
    Characterising neuropsychiatric disorders in patients with COVID-19.
    Lancet Psychiatry. 2020;7:933-934.
    PubMed        

  230. TOWNSEND E
    COVID-19 policies in the UK and consequences for mental health.
    Lancet Psychiatry. 2020 Oct 15. pii: S2215-0366(20)30457.
    PubMed        

  231. JAGUGA F, Kiburi SK
    Reducing alcohol misuse during the COVID-19 pandemic in Kenya.
    Lancet Psychiatry. 2020;7:935-936.
    PubMed        


    Lancet Respir Med

  232. BANGASH MN, Owen A, Alderman JE, Chotalia M, et al
    COVID-19 recovery: potential treatments for post-intensive care syndrome.
    Lancet Respir Med. 2020 Oct 12. pii: S2213-2600(20)30457.
    PubMed        

  233. WILLIAMSON L
    Obstructive sleep apnoea: latest surgical advances and considerations during the COVID-19 pandemic.
    Lancet Respir Med. 2020 Oct 16. pii: S2213-2600(20)30464.
    PubMed        

  234. NAKSHBANDI G, Moor CC, Wijsenbeek MS
    Home monitoring for patients with ILD and the COVID-19 pandemic.
    Lancet Respir Med. 2020 Oct 16. pii: S2213-2600(20)30452.
    PubMed        

  235. WOOLVEN S
    A call for Essays: stories from the frontline during the COVID-19 pandemic.
    Lancet Respir Med. 2020 Oct 13. pii: S2213-2600(20)30463.
    PubMed        

  236. LEISMAN DE, Ronner L, Pinotti R, Taylor MD, et al
    Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes.
    Lancet Respir Med. 2020 Oct 16. pii: S2213-2600(20)30404.
    PubMed         Abstract available


    Life Sci

  237. BAILLY C, Vergoten G
    Mechanistic insights into dimethyl cardamonin-mediated pharmacological effects: A double control of the AMPK-HMGB1 signaling axis.
    Life Sci. 2020 Oct 18:118601. doi: 10.1016/j.lfs.2020.118601.
    PubMed         Abstract available

  238. MORRIS G, Bortolasci CC, Puri BK, Olive L, et al
    Preventing the development of severe CoVID 19 by modifying immunothrombosis.
    Life Sci. 2020 Oct 20:118617. doi: 10.1016/j.lfs.2020.118617.
    PubMed         Abstract available


    MMWR Morb Mortal Wkly Rep

  239. CATES J, Lucero-Obusan C, Dahl RM, Schirmer P, et al
    Risk for In-Hospital Complications Associated with COVID-19 and Influenza - Veterans Health Administration, United States, October 1, 2018-May 31, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1528-1534.
    PubMed         Abstract available

  240. ROSSEN LM, Branum AM, Ahmad FB, Sutton P, et al
    Excess Deaths Associated with COVID-19, by Age and Race and Ethnicity - United States, January 26-October 3, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1522-1527.
    PubMed         Abstract available

  241. OSTER AM, Caruso E, DeVies J, Hartnett KP, et al
    Transmission Dynamics by Age Group in COVID-19 Hotspot Counties - United States, April-September 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1494-1496.
    PubMed         Abstract available

  242. CZEISLER ME, Garcia-Williams AG, Molinari NA, Gharpure R, et al
    Demographic Characteristics, Experiences, and Beliefs Associated with Hand Hygiene Among Adults During the COVID-19 Pandemic - United States, June 24-30, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1485-1491.
    PubMed         Abstract available

  243. ATRUBIN D, Wiese M, Bohinc B
    An Outbreak of COVID-19 Associated with a Recreational Hockey Game - Florida, June 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1492-1493.
    PubMed         Abstract available

  244. WILSON RF, Sharma AJ, Schluechtermann S, Currie DW, et al
    Factors Influencing Risk for COVID-19 Exposure Among Young Adults Aged 18-23 Years - Winnebago County, Wisconsin, March-July 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1497-1502.
    PubMed         Abstract available

  245. HONG SY, Ashipala LSN, Bikinesi L, Hamunime N, et al
    Rapid Adaptation of HIV Treatment Programs in Response to COVID-19 - Namibia, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1549-1551.
    PubMed         Abstract available

  246. CHIPIMO PJ, Barradas DT, Kayeyi N, Zulu PM, et al
    First 100 Persons with COVID-19 - Zambia, March 18-April 28, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1547-1548.
    PubMed         Abstract available

  247. HILL HA, Yankey D, Elam-Evans LD, Singleton JA, et al
    Vaccination Coverage by Age 24 Months Among Children Born in 2016 and 2017 - National Immunization Survey-Child, United States, 2017-2019.
    MMWR Morb Mortal Wkly Rep. 2020;69:1505-1511.
    PubMed         Abstract available

  248. GOLD JAW, Rossen LM, Ahmad FB, Sutton P, et al
    Race, Ethnicity, and Age Trends in Persons Who Died from COVID-19 - United States, May-August 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1517-1521.
    PubMed         Abstract available

  249. MURRAY MT, Riggs MA, Engelthaler DM, Johnson C, et al
    Mitigating a COVID-19 Outbreak Among Major League Baseball Players - United States, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1542-1546.
    PubMed         Abstract available

  250. DASGUPTA S, Bowen VB, Leidner A, Fletcher K, et al
    Association Between Social Vulnerability and a County's Risk for Becoming a COVID-19 Hotspot - United States, June 1-July 25, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1535-1541.
    PubMed         Abstract available


    N Engl J Med

  251. BELOT A, Levy-Bruhl D
    Multisystem Inflammatory Syndrome in Children in the United States.
    N Engl J Med. 2020;383.
    PubMed        

  252. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Vaccinology and Covid-19.
    N Engl J Med. 2020;383:e109.
    PubMed        

  253. KASER A
    Genetic Risk of Severe Covid-19.
    N Engl J Med. 2020;383:1590-1591.
    PubMed        

  254. WALSH EE, Frenck RW Jr, Falsey AR, Kitchin N, et al
    Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.
    N Engl J Med. 2020 Oct 14. doi: 10.1056/NEJMoa2027906.
    PubMed         Abstract available

  255. SHAPIRO J, McDonald TB
    Supporting Clinicians during Covid-19 and Beyond - Learning from Past Failures and Envisioning New Strategies.
    N Engl J Med. 2020 Oct 14. doi: 10.1056/NEJMp2024834.
    PubMed        


  256. Dying in a Leadership Vacuum.
    N Engl J Med. 2020;383:1479-1480.
    PubMed        

  257. CUNEO CN, Janeway H
    From Icebox to Tinderbox - A View from the Southern Border.
    N Engl J Med. 2020;383:e81.
    PubMed        

  258. RAFIEI Y, Mello MM
    The Missing Piece - SARS-CoV-2 Testing and School Reopening.
    N Engl J Med. 2020 Oct 21. doi: 10.1056/NEJMp2028209.
    PubMed        

  259. STONE JH, Frigault MJ, Serling-Boyd NJ, Fernandes AD, et al
    Efficacy of Tocilizumab in Patients Hospitalized with Covid-19.
    N Engl J Med. 2020 Oct 21. doi: 10.1056/NEJMoa2028836.
    PubMed         Abstract available

  260. CHOWDHURY JF, Moores LK, Connors JM
    Anticoagulation in Hospitalized Patients with Covid-19.
    N Engl J Med. 2020;383:1675-1678.
    PubMed        

  261. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Tocilizumab and Covid-19.
    N Engl J Med. 2020;383:e114.
    PubMed        

  262. STRASSLE C, Jardas E, Ochoa J, Berkman BE, et al
    Covid-19 Vaccine Trials and Incarcerated People - The Ethics of Inclusion.
    N Engl J Med. 2020 Oct 21. doi: 10.1056/NEJMp2025955.
    PubMed        

  263. GOODING R, Myers B, Salta S
    Lupus Anticoagulant in Patients with Covid-19.
    N Engl J Med. 2020;383.
    PubMed        

  264. PLATTON S, Bowles L, Pasi KJ
    Lupus Anticoagulant in Patients with Covid-19. Reply.
    N Engl J Med. 2020;383.
    PubMed        

  265. BROSSEAU LM, Roy CJ, Osterholm MT
    Facial Masking for Covid-19.
    N Engl J Med. 2020;383.
    PubMed        

  266. GANDHI M, Rutherford GW
    Facial Masking for Covid-19. Reply.
    N Engl J Med. 2020;383.
    PubMed        

  267. HATA SR
    The Ritual of the Table.
    N Engl J Med. 2020;383:1301-1303.
    PubMed        

  268. RASMUSSEN AL, Escandon K, Popescu SV
    Facial Masking for Covid-19.
    N Engl J Med. 2020;383.
    PubMed        

  269. WARREN RC, Forrow L, Hodge DA Sr, Truog RD, et al
    Trustworthiness before Trust - Covid-19 Vaccine Trials and the Black Community.
    N Engl J Med. 2020 Oct 16. doi: 10.1056/NEJMp2030033.
    PubMed        


    Nature

  270. ASCHWANDEN C
    The false promise of herd immunity for COVID-19.
    Nature. 2020 Oct 21. pii: 10.1038/d41586-020-02948.
    PubMed        

  271. WILLYARD C
    How anti-ageing drugs could boost COVID vaccines in older people.
    Nature. 2020;586:352-354.
    PubMed        

  272. ENDESFELDER U, Pfluger D, de Wolff T
    #StopPandemicBias: scientists, share your privilege.
    Nature. 2020;583:683.
    PubMed        

  273. WOOLSTON C
    Signs of depression and anxiety soar among US graduate students during pandemic.
    Nature. 2020;585:147-148.
    PubMed        

  274. SAMPSON C, Vamosi SM
    Don't let COVID stop your fieldwork: three tips for successful collaborations.
    Nature. 2020 Oct 15. pii: 10.1038/d41586-020-02903.
    PubMed        

  275. SCHIERMEIER Q, Else H, Rodriguez Mega E, Padma TV, et al
    What it's really like to do science amid COVID-19.
    Nature. 2020;586:486-487.
    PubMed        

  276. SUBBARAO K
    COVID-19 vaccines: time to talk about the uncertainties.
    Nature. 2020;586:475.
    PubMed        

  277. GAEBLER C, Nussenzweig MC
    All eyes on a hurdle race for a SARS-CoV-2 vaccine.
    Nature. 2020;586:501-502.
    PubMed        

  278. MUTESA L, Ndishimye P, Butera Y, Souopgui J, et al
    A pooled testing strategy for identifying SARS-CoV-2 at low prevalence.
    Nature. 2020 Oct 21. pii: 10.1038/s41586-020-2885.
    PubMed         Abstract available


  279. Nature's second pandemic progress report.
    Nature. 2020;586:473-474.
    PubMed        

  280. CALLAWAY E
    Dozens to be deliberately infected with coronavirus in UK 'human challenge' trials.
    Nature. 2020 Oct 20. pii: 10.1038/d41586-020-02821.
    PubMed        

  281. LEDFORD H
    How obesity could create problems for a COVID vaccine.
    Nature. 2020;586:488-489.
    PubMed        

  282. MUNDT AP
    Question hubris in nations' COVID-19 responses.
    Nature. 2020;586:500.
    PubMed        

  283. MEGA ER
    Latin America's embrace of an unproven COVID treatment is hindering drug trials.
    Nature. 2020;586:481-482.
    PubMed        


    Radiology

  284. MENG X, Liu Y
    Chest Imaging Tests versus RT-PCR Testing for COVID-19 Pneumonia: There Is No Best, Only a Better Fit.
    Radiology. 2020 Oct 20:203792. doi: 10.1148/radiol.2020203792.
    PubMed        


    Science

  285. SHAMAN J, Galanti M
    Will SARS-CoV-2 become endemic?
    Science. 2020 Oct 14. pii: science.abe5960. doi: 10.1126/science.abe5960.
    PubMed         Abstract available

  286. DE OLIVEIRA G, Chen JM, Stark SC, Berenguer E, et al
    Smoke pollution's impacts in Amazonia.
    Science. 2020;369:634-635.
    PubMed        

  287. COUZIN-FRANKEL J
    The long haul.
    Science. 2020;369:614-617.
    PubMed        

  288. SERVICE RF
    Fast, cheap tests could enable safer reopening.
    Science. 2020;369:608-609.
    PubMed        

  289. WADMAN M
    Why infection poses a special risk to pregnant women.
    Science. 2020;369:606-607.
    PubMed        

  290. LIPSITCH M, Dean NE
    Understanding COVID-19 vaccine efficacy.
    Science. 2020 Oct 21. pii: science.abe5938. doi: 10.1126/science.abe5938.
    PubMed         Abstract available

  291. COLLINS C
    Productivity in a pandemic.
    Science. 2020;369:603.
    PubMed        

  292. GORDON DE, Hiatt J, Bouhaddou M, Rezelj VV, et al
    Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.
    Science. 2020 Oct 15. pii: science.abe9403. doi: 10.1126/science.abe9403.
    PubMed         Abstract available

  293. KAISER J
    Found: genes that sway the course of the coronavirus.
    Science. 2020;370:275-276.
    PubMed        

  294. ANDRIJEVIC M, Schleussner CF, Gidden MJ, McCollum DL, et al
    COVID-19 recovery funds dwarf clean energy investment needs.
    Science. 2020;370:298-300.
    PubMed        

  295. LANGIN K
    Pandemic hits scientist parents hard.
    Science. 2020;369:609-610.
    PubMed        

  296. DALY JL, Simonetti B, Klein K, Chen KE, et al
    Neuropilin-1 is a host factor for SARS-CoV-2 infection.
    Science. 2020 Oct 20. pii: science.abd3072. doi: 10.1126/science.abd3072.
    PubMed         Abstract available

  297. BANGARU S, Ozorowski G, Turner HL, Antanasijevic A, et al
    Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate.
    Science. 2020 Oct 20. pii: science.abe1502. doi: 10.1126/science.abe1502.
    PubMed         Abstract available

  298. BECK DB, Aksentijevich I
    Susceptibility to severe COVID-19.
    Science. 2020;370:404-405.
    PubMed        

  299. LEE EC, Wada NI, Grabowski MK, Gurley ES, et al
    The engines of SARS-CoV-2 spread.
    Science. 2020;370:406-407.
    PubMed        

  300. CANTUTI-CASTELVETRI L, Ojha R, Pedro LD, Djannatian M, et al
    Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity.
    Science. 2020 Oct 20. pii: science.abd2985. doi: 10.1126/science.abd2985.
    PubMed         Abstract available


    Travel Med Infect Dis

  301. MALEKI M, Mahmoudi MR, Wraith D, Pho KH, et al
    Time series modelling to forecast the confirmed and recovered cases of COVID-19.
    Travel Med Infect Dis. 2020;37:101742.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO COVID-19 is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: